Gene · 910
Papers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,023
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. | Pharmaceutics | 2022 | 36559094 | PubTator, text mining | PubMed |
| The Role of Sphingolipids in the Pathogenesis of Psoriasis. | Metabolites | 2022 | 36557209 | PubTator, text mining | PubMed |
| Activation Mechanism of RhoA Caused by Constitutively Activating Mutations G14V and Q63L. | Int J Mol Sci | 2022 | 36555100 | PubTator, text mining | PubMed |
| An Efficient AP-ANN-Based Multimethod Fusion Model to Detect Stress through EEG Signal Analysis. | Comput Intell Neurosci | 2022 | 36544857 | PubTator, text mining | PubMed |
| Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids. | Front Immunol | 2022 | 36544778 | PubTator, text mining | PubMed |
| The repertoire of protein-sulfatide interactions reveal distinct modes of sulfatide recognition. | Front Mol Biosci | 2022 | 36533082 | PubTator, text mining | PubMed |
| Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases. | Nat Commun | 2022 | 36513651 | PubTator, text mining | PubMed |
| Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors. | Molecules | 2022 | 36500328 | PubTator, text mining | PubMed |
| CD1a promotes systemic manifestations of skin inflammation. | Nat Commun | 2022 | 36477177 | PubTator, text mining | PubMed |
| Structural basis of sequence-specific RNA recognition by the antiviral factor APOBEC3G. | Nat Commun | 2022 | 36470880 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type. | Aging Dis | 2022 | 36465169 | PubTator, text mining | PubMed |
| CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation. | Aging (Albany NY) | 2022 | 36445333 | PubTator, text mining | PubMed |
| Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification. | EBioMedicine | 2022 | 36442320 | PubTator, text mining | PubMed |
| Overlapping Machinery in Lysosome-Related Organelle Trafficking: A Lesson from Rare Multisystem Disorders. | Cells | 2022 | 36429129 | PubTator, text mining | PubMed |
| Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action. | Clin Cosmet Investig Dermatol | 2022 | 36415541 | PubTator, text mining | PubMed |
| SMAD6-deficiency in human genetic disorders. | NPJ Genom Med | 2022 | 36414630 | PubTator, text mining | PubMed |
| Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models. | Front Oncol | 2022 | 36408162 | PubTator, text mining | PubMed |
| Quantitative affinity measurement of small molecule ligand binding to major histocompatibility complex class-I-related protein 1 MR1. | J Biol Chem | 2022 | 36403855 | PubTator, text mining | PubMed |
| MR1: An unconventional twist in the tail. | J Cell Biol | 2022 | 36374222 | PubTator, text mining | PubMed |
In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2. | Molecules | 2022 | 36364398 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/910/papers?page=11